查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786759

體外轉錄模板的全球市場

In-Vitro Transcription Templates
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 242 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球體外轉錄模板市場規模將達 10 億美元

全球體外轉錄模板市場規模預計在2024年達到3.585億美元，預計在分析期內（2024-2030年）將以18.9%的複合年成長率成長，到2030年將達到10億美元。 DNA模板是本報告分析的細分市場之一，預計其複合年成長率將達到17.3%，到分析期結束時達到3.953億美元。 RNA模板細分市場在分析期間內的複合年成長率預計為17.5%。

美國市場規模估計為 9,420 萬美元，中國市場預計複合年成長率為 17.9%

美國體外轉錄模板市場規模預計在2024年達到9,420萬美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到1.562億美元，在2024-2030年的分析期間內，複合年成長率為17.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為17.1%和16.5%。在歐洲，預計德國市場的複合年成長率約為14.0%。

體外轉錄模板－主要趨勢與市場促進因素摘要

體外轉錄 (IVT) 模板已成為分子生物學、生物技術和生物製藥研究中必不可少的工具，為各種應用的 RNA 合成提供了基礎。這些模板通常源自 DNA質體或線性 DNA 片段，可用於生產用於 mRNA 療法、疫苗開發、基因治療和基於 CRISPR 的基因組編輯的合成 RNA。對高純度、可擴展 RNA 合成的需求日益成長，尤其是在基於 mRNA 的疫苗和治療方法的開發方面，這極大地推動了 IVT 模板技術的進步。隨著 RNA 藥物的不斷擴展，對最佳化且高效的 IVT 模板的需求正在顯著改變合成生物學和治療方法開發的模式。

科技創新如何增強體外轉錄模板？

IVT模板設計和合成技術的進步顯著提高了體外轉錄RNA的效率、穩定性和產量。其中最顯著的創新之一是開發了最佳化的啟動子序列以提高轉錄效率。 T7、SP6和T3 RNA聚合酵素啟動子已被廣泛改造，以最大限度地提高RNA產量，同時最大限度地減少不必要的副產物，例如截短的RNA和異常的RNA。此外，改進的poly(A)加尾策略和5'-加帽技術已納入IVT模板設計中，以提高RNA的穩定性和翻譯效率，從而用於治療應用。

另一項關鍵創新是轉向使用基於PCR方法產生的線性DNA模板。與質體DNA模板不同，線性DNA片段無需純化超螺旋質體，從而降低了製程複雜性並提高了批次間一致性。高保真DNA聚合酵素和模板工程策略的使用進一步提高了IVT模板的品質和擴充性，使其更適合大規模RNA生產。此外，CleanCap™和Cap1構建等酶促加帽方法的整合顯著提高了合成RNA的功能穩定性，這對於基於mRNA的疫苗和療法至關重要。

哪些市場趨勢推動了 IVT 模板的演變？

基於 mRNA 的 COVID-19 疫苗已證明 IVT 產生的 RNA 在快速藥物開發方面具有巨大潛力。這項成功刺激了對 RNA 藥物研發管線的大量投資，製藥和生物技術公司正在擴展 IVT 模板能力，以用於癌症免疫療法、蛋白質替代療法和個人化疫苗。 mRNA 技術在感染疾病疫苗、自體免疫疾病和罕見遺傳疾病領域的應用日益廣泛，這推動了 IVT 模板最佳化領域的創新。

另一個重要趨勢是人們對基於 CRISPR 的基因編輯技術的興趣日益濃厚，其中 IVT 模板在嚮導 RNA (gRNA) 的合成中起著關鍵作用。隨著 CRISPR-Cas9 及相關技術的不斷發展，對高純度、精準設計的 RNA 轉錄本的需求日益成長。這推動了模板純化策略、無錯誤合成方法和可擴展生產過程的進步，以確保基因組編輯應用的高保真度。

此外，合成生物學和基於RNA的診斷技術的擴展正在塑造IVT模板市場。研發人員正在利用IVT模板製造RNA感測器、RNA適體和生物感測技術，進而推動下一代分子診斷技術的開發。這一趨勢對於感染疾病診斷中的就地檢驗（POCT）和快速核酸檢測尤其重要，因為IVT產生的RNA探針可以提高檢測的敏感度和特異性。

推動 IVT 模板市場成長的因素有哪些？

體外轉錄模板市場的成長受到多種因素的推動，包括對基於RNA的療法的需求不斷成長、模板合成技術的進步以及在生物技術和分子醫學領域的應用不斷拓展。 mRNA藥物開發平臺的快速擴張是其關鍵的成長要素。 mRNA疫苗的成功促使製藥公司和研究機構的投資激增，他們致力於開發針對多種疾病的新型RNA治療方法，推動了對最佳化IVT模板的需求。

在基於 CRISPR 的基因編輯和細胞療法應用中，IVT 模板的日益普及也是推動市場成長的主要因素。基因編輯技術的進步正在加速對高品質 IVT 生成的嚮導 RNA 和模板驅動的 RNA 分子的需求，從而支持基因治療、再生醫學和精準醫療領域的突破。此外，對個人化醫療和 RNA 診斷的日益關注也推動了對可擴展和可自訂 IVT 模板解決方案的需求。

向酶合成和高純度RNA製造的轉變也是製藥和生物技術公司尋求簡化RNA製造流程並維持嚴格品管標準的關鍵驅動力。隨著監管部門對RNA療法的關注日益增加，各公司正在投資先進的模板合成技術，例如無錯誤轉錄系統和無污染酶促方法，以確保符合良好生產規範(GMP)。此外，學術研究機構、生物技術公司以及受託製造廠商(CDMO)之間的合作正在加速IVT模板的創新，從而實現RNA療法的大規模生產和商業化。

隨著基於 RNA 的藥物繼續徹底改變醫療保健，對高效、可擴展且精確設計的體外轉錄模板的需求預計將擴大並塑造合成生物學、基因醫學和生物製藥開發的未來。

部分

產品類型（DNA模板、RNA模板、模板及轉錄套件、其他產品類型）；疾病（文明病、遺傳疾病、其他）；治療（疫苗、治療學）；研究階段（探索性、臨床）；最終用戶（製藥和生物技術公司、學術和研究機構、受託研究機構）

受訪公司範例

  • Agilent Technologies Inc.
  • Aldevron
  • Bio-Rad Laboratories Inc.
  • Bio-Synthesis Inc.
  • Cayman Chemical
  • Creative Diagnostics
  • Danaher Corporation
  • Enzo Life Sciences Inc.
  • Enzynomics Co., Ltd.
  • Eurofins Genomics LLC
  • Genaxxon BioScience GmbH
  • GeneCopoeia
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corporation
  • OriGene Technologies Inc.
  • Promega Corporation
  • Qiagen NV
  • Synbio Technologies
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies
  • Vazyme Biotech Co., Ltd.
  • VectorBuilder Inc.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP31688

Global In-Vitro Transcription Templates Market to Reach US$1.0 Billion by 2030

The global market for In-Vitro Transcription Templates estimated at US$358.5 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 18.9% over the analysis period 2024-2030. DNA templates, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$395.3 Million by the end of the analysis period. Growth in the RNA templates segment is estimated at 17.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$94.2 Million While China is Forecast to Grow at 17.9% CAGR

The In-Vitro Transcription Templates market in the U.S. is estimated at US$94.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$156.2 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.1% and 16.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.0% CAGR.

In-Vitro Transcription Templates - Key Trends & Market Drivers Summarized

In-vitro transcription (IVT) templates have become an essential tool in molecular biology, biotechnology, and biopharmaceutical research, serving as the foundation for RNA synthesis in various applications. These templates, typically derived from DNA plasmids or linear DNA fragments, enable the production of synthetic RNA for mRNA therapeutics, vaccine development, gene therapy, and CRISPR-based genome editing. The increasing demand for high-purity and scalable RNA synthesis, particularly in the development of mRNA-based vaccines and therapies, has significantly boosted advancements in IVT template technology. As RNA-based medicine continues to expand, the need for optimized and efficient IVT templates is reshaping the landscape of synthetic biology and therapeutic development.

How Are Technological Innovations Enhancing In-Vitro Transcription Templates?

Technological advancements in IVT template design and synthesis have significantly improved the efficiency, stability, and yield of in-vitro transcribed RNA. One of the most notable innovations is the development of optimized promoter sequences that enhance transcription efficiency. The T7, SP6, and T3 RNA polymerase promoters have been extensively engineered to maximize RNA yield while minimizing unwanted byproducts such as truncated or aberrant RNA species. Additionally, modifications in poly(A) tailing strategies and 5' capping technologies have been integrated into IVT template designs to improve RNA stability and translational efficiency for therapeutic applications.

Another key innovation is the shift toward linear DNA templates generated through PCR-based methods. Unlike plasmid DNA templates, linear DNA fragments eliminate the need for supercoiled plasmid purification, reducing process complexity and improving batch-to-batch consistency. The use of high-fidelity DNA polymerases and template engineering strategies has further enhanced the quality and scalability of IVT templates, making them more suitable for large-scale RNA production. Furthermore, the integration of enzymatic capping methods such as CleanCap™ and Cap1 structures has significantly improved the functional stability of synthetic RNA, which is crucial for mRNA-based vaccines and therapeutics.

What Market Trends Are Driving the Evolution of IVT Templates?

The rise of mRNA therapeutics and vaccines has been the most transformative trend in the IVT template market, with mRNA-based COVID-19 vaccines demonstrating the vast potential of IVT-generated RNA for rapid drug development. This success has spurred significant investment in RNA-based drug pipelines, with pharmaceutical companies and biotech firms expanding their IVT template capabilities for cancer immunotherapies, protein replacement therapies, and personalized vaccines. The increasing adoption of mRNA-based technologies in infectious disease vaccines, autoimmune disorders, and rare genetic conditions is driving innovation in IVT template optimization.

Another critical trend is the growing interest in CRISPR-based gene editing, where IVT templates serve as a key component in the synthesis of guide RNAs (gRNAs). As CRISPR-Cas9 and related technologies continue to evolve, the demand for highly pure and precisely engineered RNA transcripts is increasing. This has led to advancements in template purification strategies, error-free synthesis methods, and scalable production processes to ensure high fidelity in genome editing applications.

Additionally, the expansion of synthetic biology and RNA-based diagnostics is shaping the IVT template market. Researchers are leveraging IVT templates for the production of RNA sensors, RNA aptamers, and biosensing technologies, enabling the development of next-generation molecular diagnostics. This trend is particularly relevant for point-of-care testing (POCT) and rapid nucleic acid detection in infectious disease diagnostics, where IVT-generated RNA probes enhance assay sensitivity and specificity.

What Is Driving the Growth of the IVT Template Market?

The growth in the in-vitro transcription template market is driven by several factors, including the increasing demand for RNA-based therapies, advancements in template synthesis technologies, and expanding applications in biotechnology and molecular medicine. A major growth driver is the rapid expansion of mRNA-based drug development pipelines. The success of mRNA vaccines has prompted a surge in investment from pharmaceutical companies and research institutions seeking to develop novel RNA-based treatments for a wide range of diseases, thereby increasing the need for optimized IVT templates.

Another significant factor fueling market growth is the rising adoption of IVT templates in CRISPR-based gene editing and cell therapy applications. As gene-editing technologies advance, the demand for high-quality IVT-generated guide RNAs and template-driven RNA molecules is accelerating, supporting breakthroughs in gene therapy, regenerative medicine, and precision medicine. Additionally, the increasing focus on personalized medicine and RNA-based diagnostics is driving the need for scalable and customizable IVT template solutions.

The shift toward enzymatic synthesis and high-purity RNA production is also a crucial driver, as pharmaceutical and biotech companies seek to streamline RNA manufacturing processes while maintaining stringent quality standards. With the growing regulatory emphasis on RNA therapeutics, companies are investing in advanced template synthesis techniques, including error-free transcription systems and contamination-free enzymatic approaches, to ensure compliance with Good Manufacturing Practice (GMP) standards. Furthermore, the collaborations between academic research institutions, biotech firms, and contract development and manufacturing organizations (CDMOs) are accelerating IVT template innovation, enabling large-scale production and commercialization of RNA-based therapeutics.

As RNA-based medicine continues to revolutionize healthcare, the demand for highly efficient, scalable, and precisely engineered in-vitro transcription templates is expected to grow, shaping the future of synthetic biology, genetic medicine, and biopharmaceutical development.

SCOPE OF STUDY:

The report analyzes the In-Vitro Transcription Templates market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (DNA templates, RNA templates, Templates & transcription kits, Other product types); Disease (Lifestyle disease, Genetic disease, Other diseases); Treatment (Vaccine, Therapeutic); Research Stage (Exploratory, Clinical); End-Use (Pharma & Biotech Companies, Academic & Research institutes, Contract research organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Agilent Technologies Inc.
  • Aldevron
  • Bio-Rad Laboratories Inc.
  • Bio-Synthesis Inc.
  • Cayman Chemical
  • Creative Diagnostics
  • Danaher Corporation
  • Enzo Life Sciences Inc.
  • Enzynomics Co., Ltd.
  • Eurofins Genomics LLC
  • Genaxxon BioScience GmbH
  • GeneCopoeia
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corporation
  • OriGene Technologies Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Synbio Technologies
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies
  • Vazyme Biotech Co., Ltd.
  • VectorBuilder Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • In-Vitro Transcription Templates - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Expansion of mRNA Therapeutics and Vaccines Drives High-Volume Demand for IVT Templates
    • Growth in Cell and Gene Therapy R&D Strengthens Role of IVT Templates in Vector and RNA Synthesis
    • OEM Partnerships With CDMOs and Biotech Firms Spur Template Customization and Scale-Up Innovation
    • Rising Adoption of Self-Amplifying RNA and Circular RNA Boosts Need for Specialized Transcription Templates
    • Increased Investment in Personalized Cancer Vaccines Enhances Market for Custom IVT Template Production
    • Integration of IVT Templates Into Synthetic Biology Platforms Expands Application Beyond Therapeutics
    • Improved Plasmid Linearization and Template Purity Enhances Transcription Efficiency and Yield
    • Use of Enzyme-Modified and Cap-Integrated Templates Accelerates Translation Efficiency
    • Emerging Use of IVT in CRISPR Guide RNA Production Creates New Use Cases Across Research Fields
    • OEM Need for Templates With Regulatory-Grade Consistency Promotes GMP-Compliant Manufacturing
    • Increased Focus on Template Scalability Supports Transition From Bench to Clinic
    • IVT Template Supply Chain Resilience Becomes Critical Amid Global mRNA Development Booms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World In-Vitro Transcription Templates Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for In-Vitro Transcription Templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for DNA templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for DNA templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for RNA templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for RNA templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Templates & transcription kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Templates & transcription kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other product types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other product types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Exploratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Exploratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Academic & Research institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Academic & Research institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Contract research organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Contract research organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Lifestyle disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Lifestyle disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Genetic disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Genetic disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • JAPAN
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • CHINA
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • EUROPE
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 72: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for In-Vitro Transcription Templates by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • FRANCE
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 84: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • GERMANY
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 94: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • UNITED KINGDOM
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 114: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • ASIA-PACIFIC
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 144: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030

IV. COMPETITION